BioPharma Intelligence Hub
FDA catalyst tracker, drug pipeline monitor & clinical trial data for 0 biotech companies. Free data from FDA, SEC EDGAR & ClinicalTrials.gov.
Upcoming Catalysts
No upcoming catalysts in the next 14 days. Data is being populated.
BioPharma Companies
Company data is being populated from SEC EDGAR. Check back shortly.
What is the BioPharma Intelligence Hub?
A free, data-driven platform that aggregates information from official US government sources to help you track pharmaceutical and biotechnology company developments. All data comes from public domain sources: the U.S. Food & Drug Administration (FDA), the Securities and Exchange Commission (SEC EDGAR), and the National Library of Medicine (ClinicalTrials.gov).
Catalyst Calendar
Track upcoming PDUFA dates, AdCom meetings, Phase 3 readouts, and other FDA regulatory events.
View Calendar →Company Pipelines
Explore drug pipelines for 800+ biotech and pharma companies with trial status and regulatory timelines.
Browse Companies →Clinical Trials
Monitor active clinical trials from ClinicalTrials.gov, organized by company, phase, and indication.
SEC Filings
FDA-related 8-K filings parsed and organized by company. Direct links to SEC EDGAR source documents.
Pipeline Development Grades
Companies are assessed using a transparent, published methodology based on objective data points. Grades reflect pipeline development progress, not investment merit.